Kiley Juergens Wealth Management LLC Increases Stock Position in Kenvue Inc. (NYSE:KVUE)

Kiley Juergens Wealth Management LLC lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 18.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 27,586 shares of the company’s stock after acquiring an additional 4,252 shares during the quarter. Kiley Juergens Wealth Management LLC’s holdings in Kenvue were worth $594,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of KVUE. Vanguard Group Inc. purchased a new stake in Kenvue in the 3rd quarter worth approximately $2,944,816,000. FMR LLC increased its holdings in shares of Kenvue by 572.1% in the 3rd quarter. FMR LLC now owns 89,182,980 shares of the company’s stock worth $1,790,794,000 after buying an additional 75,913,107 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of Kenvue by 576.1% in the 3rd quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company’s stock worth $1,439,472,000 after buying an additional 61,084,123 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Kenvue by 227.7% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 61,091,189 shares of the company’s stock worth $1,226,711,000 after buying an additional 42,449,470 shares during the last quarter. Finally, Morgan Stanley increased its holdings in shares of Kenvue by 4,057.4% in the 3rd quarter. Morgan Stanley now owns 31,162,614 shares of the company’s stock worth $625,745,000 after buying an additional 30,413,040 shares during the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on KVUE shares. William Blair started coverage on shares of Kenvue in a report on Wednesday, April 3rd. They set a “market perform” rating on the stock. Royal Bank of Canada reduced their target price on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 9th. JPMorgan Chase & Co. reduced their target price on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a report on Friday, February 9th. UBS Group increased their target price on shares of Kenvue from $20.00 to $23.00 and gave the company a “neutral” rating in a report on Tuesday, December 19th. Finally, The Goldman Sachs Group started coverage on shares of Kenvue in a report on Friday, March 1st. They set a “neutral” rating and a $20.00 target price on the stock. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $24.85.

Kenvue Stock Performance

Shares of NYSE KVUE traded down $0.02 during midday trading on Tuesday, hitting $19.11. The stock had a trading volume of 20,306,557 shares, compared to its average volume of 16,870,912. The business’s 50 day moving average is $19.88 and its 200-day moving average is $20.18. Kenvue Inc. has a 52 week low of $17.82 and a 52 week high of $27.80. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 0.69.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, February 8th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.03. Kenvue had a net margin of 9.87% and a return on equity of 15.62%. The firm had revenue of $3.67 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Kenvue’s revenue was down 2.7% compared to the same quarter last year. As a group, analysts predict that Kenvue Inc. will post 1.17 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th were issued a dividend of $0.20 per share. The ex-dividend date was Tuesday, February 13th. This represents a $0.80 dividend on an annualized basis and a yield of 4.19%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.